Inventor · disambiguated record
Evan Newell
Also filed as: NEWELL EVAN · NEWELL EVAN W
10 granted patents·13 pending applications·124 citations·filing 2002–2022
89Inventor score
Files withNEWELL MARTHA KAREN6UNIV COLORADO3UNIV COLORADO REGENTS3AGENCY SCIENCE TECH & RES2NEWELL M KAREN2
Top patents by PatentIndex Score
23 records- 0193US10420813B2Competitive inhibitors of invariant chain expression and/or ectopic clip bindingREGENTS OF THE UNIV OF COLORADO A BODY CORPORATE·Filed 2016·Granted Sep 24, 2019·31 cites·12 claims
- 0293US7445794B1Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitorsUNIV COLORADO·Filed 2005·Granted Nov 4, 2008·38 cites·10 claims
- 0389US8557764B2Methods of modulating immune functionNEWELL MARTHA KAREN·Filed 2008·Granted Oct 15, 2013·16 cites·7 claims
- 0489US8293240B2Method of treating drug-resistant cancerNEWELL MARTHA KAREN·Filed 2009·Granted Oct 23, 2012·10 cites·12 claims
- 0587US8957031B2Competitive inhibitors of invariant chain expression and/or ectopic clip bindingNEWELL MARTHA KAREN·Filed 2008·Granted Feb 17, 2015·3 cites·6 claims
- 0686US7510710B2Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitorUNIV COLORADO·Filed 2005·Granted Mar 31, 2009·12 cites·6 claims
- 0774US8329753B2Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibitionNEWELL MARTHA KAREN·Filed 2006·Granted Dec 11, 2012·2 cites·6 claims
- 0873US9359404B2Methods and products for treating preeclampsia and modulating blood pressureSCOTT & WHITE HEALTHCARE·Filed 2012·Granted Jun 7, 2016·2 cites·13 claims
- 0969US2020069766A1Competitive inhibitors of invariant chain expression and/or ectopic clip bindingUNIV COLORADO REGENTS·Filed 2019·Application pending·0 cites
- 1068US8071645B2Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitorsNEWELL M KAREN·Filed 2004·Granted Dec 6, 2011·10 cites·34 claims
- 1158US2010166782A1Clip inhibitors and methods of modulating immune functionNEWELL MARTHA KAREN·Filed 2009·Application pending·0 cites
- 1256US2015231195A1Competitive inhibitors of invariant chain expression and/or ectopic clip bindingUNIV COLORADO REGENTS·Filed 2015·Application pending·0 cites
- 1353US2025003973A1Synthetic constructs and methods for processing antigen-specific cellsFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 1453US2010034839A1Methods for treating viral disordersNEWELL MARTHA KAREN·Filed 2009·Application pending·0 cites
- 1552US12414990B2Use of HLA-A*11:01-restricted hepatitis B virus (HBV) peptides for identifying HBV-specific CD8+ T cellsAGENCY SCIENCE TECH & RES·Filed 2020·Granted Sep 16, 2025·0 cites·16 claims
- 1651US2010166789A1Proteins for use in diagnosing and treating infection and diseaseUNIV COLORADO·Filed 2009·Application pending·0 cites
- 1750US2022275050A1High yield production and use of enzymatic-exchangeable peptide major histocompatibility complex class i single chain trimer tetramerAGENCY SCIENCE TECH & RES·Filed 2020·Application pending·0 cites
- 1849US2013259829A1Clip inhibitors and methods of modulating immune functionUNIV COLORADO REGENTS·Filed 2013·Application pending·0 cites
- 1946US2005048055A1Use of CD40 engagement to alter T cell receptor usageUNIV VERMONT·Filed 2004·Application pending·0 cites
- 2046US2023226135A9Acetylcholine modulation of immune functionBCELL SOLUTIONS INC·Filed 2020·Application pending·0 cites
- 2144US2012128724A1Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitorsNEWELL M KAREN·Filed 2011·Application pending·0 cites
- 2244US2016091491A1Methods for diagnosis of celiac diseaseUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 2335US2004005291A1Methods for regulating co-stimulatory molecule expression with reactive oxygenFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →